LEXX - Lexaria Bioscience appoints Mike Shankman as outsourced CFO
2023-06-12 09:49:14 ET
- Lexaria Bioscience ( NASDAQ: LEXX ) on Monday notifies that effective immediately, Mike Shankman has been appointed as outsourced CFO.
- One of Mike's current clients is a publicly traded clinical-stage biopharmaceutical company.
For further details see:
Lexaria Bioscience appoints Mike Shankman as outsourced CFO